Literature DB >> 28794097

Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn's disease and associated with decreased height.

Amanda Ricciuto1, Jennifer R Fish1, Diane E Tomalty1, Nicholas Carman1, Eileen Crowley1, Cynthia Popalis1, Aleixo Muise1, Thomas D Walters1, Anne M Griffiths1, Peter C Church1.   

Abstract

OBJECTIVES: To determine time to diagnosis in a paediatric inflammatory bowel disease (IBD) cohort and the relative contribution of the component intervals, and to identify factors associated with diagnostic delay.
DESIGN: Prospective cohort study
SETTING: Single-centre study including children with incident IBD at the Hospital for Sick Children diagnosed between December 2013 and December 2015.
INTERVENTIONS: Time to diagnosis and its subintervals were determined and patient, disease and institutional factors were tested for associations.
RESULTS: Among 111 children, the median overall time to diagnosis was 4.5 (IQR 2.1-8.8) months. Time to diagnosis was longer in Crohn's disease (CD) than ulcerative colitis (UC) (median 6.8 (IQR 2.9-12.5) vs 2.4 (IQR 1.3-5.3) months) and patients with isolated small bowel disease. Twenty per cent of patients were diagnosed≥1 year after symptom onset (86% CD, 14% UC, p=0.003). Time from symptom onset to gastroenterology referral was the greatest contributor to overall time to diagnosis (median 2.9 (IQR 1.6-8.2) months). Height impairment was independently associated with diagnostic delay (OR 0.59, p=0.02, for height-for-age z-score (HAZ), signifying almost 70% increased odds of delay for every 1 SD decrease in HAZ). This height discrepancy persisted 1 year after diagnosis. Bloody diarrhoea was protective against delay (OR 0.28, p=0.02). The subinterval from referral to diagnosis was shorter in patients with laboratory abnormalities, particularly hypoalbuminaemia.
CONCLUSIONS: Diagnostic delay was more common in CD and associated with height impairment that persisted 1 year after presentation. The greatest contributor to time to diagnosis was time from symptom onset to referral. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  gastroenterology; general paediatrics; growth

Mesh:

Year:  2017        PMID: 28794097     DOI: 10.1136/archdischild-2017-313060

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.

Authors:  J Dhaliwal; T D Walters; D R Mack; H Q Huynh; K Jacobson; A R Otley; J Debruyn; W El-Matary; C Deslandres; M E Sherlock; J N Critch; K Bax; E Seidman; P Jantchou; A Ricciuto; M Rashid; A M Muise; E Wine; M Carroll; S Lawrence; J Van Limbergen; E I Benchimol; P Church; A M Griffiths
Journal:  J Crohns Colitis       Date:  2020-05-21       Impact factor: 9.071

2.  Time between suspected and confirmed diagnoses of Crohn's disease and ulcerative colitis in patients followed in gastroenterological practices in Germany.

Authors:  Karel Kostev; Marcel Konrad; Louis Jacob
Journal:  Int J Colorectal Dis       Date:  2018-05-02       Impact factor: 2.571

3.  Diagnostic Delay in Pediatric Inflammatory Bowel Disease: A Systematic Review.

Authors:  Aymane Ajbar; Eleanor Cross; Simbarashe Matoi; Charles A Hay; Libby M Baines; Benjamin Saunders; Adam D Farmer; James A Prior
Journal:  Dig Dis Sci       Date:  2022-03-14       Impact factor: 3.199

4.  Proton Pump Inhibitors, H2 Blocker Use, and Risk of Inflammatory Bowel Disease in Children.

Authors:  Naomi R M Schwartz; Susan Hutfless; Lisa J Herrinton; Laura B Amsden; Helene B Fevrier; Matthew Giefer; Dale Lee; David L Suskind; Joseph A C Delaney; Amanda I Phipps
Journal:  J Pediatr Pharmacol Ther       Date:  2019 Nov-Dec

Review 5.  Very early-onset inflammatory bowel disease: an integrated approach.

Authors:  Kathleen E Sullivan; Maire Conrad; Judith R Kelsen
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-12

6.  Diagnostic delay of pediatric inflammatory bowel disease in Saudi Arabia.

Authors:  Mohammad I El Mouzan; Badr I AlSaleem; Mohammed Y Hasosah; Abdulrahman A Al-Hussaini; Aziz H Al Anazi; Omar I Saadah; Ahmed A Al Sarkhy; Mohammad A Al Mofarreh; Asaad A Assiri
Journal:  Saudi J Gastroenterol       Date:  2019 Jul-Aug       Impact factor: 2.485

7.  Identification of Childhood-Onset Inflammatory Bowel Disease in Swedish Healthcare Registers: A Validation Study.

Authors:  Natalia Mouratidou; Petter Malmborg; Jacob Järås; Vignir Sigurdsson; Olof Sandström; Ulrika L Fagerberg; Gabriella Bröms; Jonas F Ludvigsson; Ola Olén
Journal:  Clin Epidemiol       Date:  2022-04-29       Impact factor: 5.814

8.  Targeted Analysis of the Gut Microbiome for Diagnosis, Prognosis and Treatment Individualization in Pediatric Inflammatory Bowel Disease.

Authors:  Christine Olbjørn; Milada Cvancarova Småstuen; Aina Elisabeth Fossum Moen
Journal:  Microorganisms       Date:  2022-06-22

Review 9.  Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.

Authors:  Marko Kumric; Tina Ticinovic Kurir; Dinko Martinovic; Piero Marin Zivkovic; Josko Bozic
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

10.  Spanish Pediatric Inflammatory Bowel Disease Diagnostic Delay Registry: SPIDER Study From Sociedad Española de Gastroenterología, Hepatología y Nutrición Pediátrica.

Authors:  Santiago Jiménez Treviño; Gemma Pujol Muncunill; Rafael Martín-Masot; Alejandro Rodríguez Martínez; Oscar Segarra Cantón; Luis Peña Quintana; Honorio Armas Ramos; Francisco Javier Eizaguirre Arocena; Josefa Barrio Torres; José Ignacio García Burriel; Luis Ortigosa Castillo; Ester Donat Aliaga; Vanesa Crujeiras Martínez; Patricia Barros García; Gonzalo Botija Arcos; Juan Manuel Bartolomé Porro; Mercedes Juste Ruiz; Carlos Ochoa Sangrador; Zuriñe García Casales; Gonzalo Galicia Poblet; Pablo Oliver Goicolea; Helena Lorenzo Garrido; Ruth García Romero; Enrique La Orden Izquierdo; David Pérez Solis; Víctor Manuel Navas-López; Juan José Díaz Martin; Javier Martín de Carpi
Journal:  Front Pediatr       Date:  2020-10-15       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.